Rockville, Maryland, United States – September 4, 2026 – South Korea-based Wooree Green Science launched its patented LipoPrime phospholipid delivery ingredient in the United States in August 2026, targeting dietary supplement and functional nutrition manufacturers seeking liposomal delivery for vitamins, botanicals, antioxidants, and other active ingredients. The technology uses controlled particle-size specifications and electron microscopy to verify liposome structure during production, reflecting the industry's growing focus on carrier quality rather than liposomal positioning alone.

According to Fact.MR, the global liposomal nutrient carriers market is valued at USD 1.2 billion in 2026 and is projected to reach USD 4.4 billion by 2036, expanding at a 13.9% CAGR during the forecast period. The market was valued at approximately USD 1.1 billion in 2025, creating an estimated absolute opportunity of USD 3.2 billion between 2026 and 2036.

Get detailed market forecasts, competitive benchmarking, and pricing trends:https://www.factmr.com/connectus/sample?flag=S&rep_id=16243

Why Liposomal Delivery Is Gaining Ground

Liposomal nutrient carriers use phospholipid vesicles to surround active compounds and influence their stability, dispersion, delivery, and absorption characteristics. The technology is increasingly being applied to vitamins, botanical extracts, minerals, omega-based actives, and specialty nutritional compounds.

For supplement manufacturers, the attraction is partly commercial. A liposomal format gives brands another way to differentiate products when conventional tablets or capsules compete on similar ingredient labels.

Phosphatidylcholine liposomes are projected to account for 43% of the carrier-architecture segment in 2026, making them the leading architecture analyzed by Fact.MR. Vitamins represent 34% of payload demand, while liquid concentrates account for 32% of delivery formats.

The shift is also visible in supplier investment. In April 2026, India's Samarth Biorigins opened a facility dedicated to advanced and customized delivery systems, including liposomal and microencapsulation technologies, with the company reporting inquiries from customers across the Middle East, Australia, and Asia.

Vitamins Remain the Largest Payload Category

Vitamins are expected to represent 34% of the liposomal nutrient carriers market in 2026.

Vitamin C, vitamin D, B-complex vitamins, vitamin E, and other micronutrients are frequently evaluated for lipid-based delivery because formulation teams can use carrier systems to address stability, dispersion, taste, and absorption considerations.

The opportunity extends to botanical ingredients. Complex botanical blends can present challenges involving stability and formulation compatibility, increasing the need for documented carrier composition and finished-product testing. Fact.MR notes that FDA amended MOU 225-19-032 effective August 1, 2025, supporting safety assessment work involving complex botanical mixtures in foods and dietary supplements.

For procurement teams, the practical question is no longer simply whether an ingredient is “liposomal.” Particle size distribution, phospholipid origin, encapsulation performance, oxidation control, stability, and payload compatibility can influence commercial qualification.

“The commercial test for liposomal nutrients is shifting toward proof of carrier quality,” said Shambhu Nath Jha, Principal Consultant at Fact.MR. He added that brands increasingly need documentation covering particle stability, phospholipid origin, and claim language before approving a formulation.

Bioavailability Claims Create Both Opportunity and Scrutiny

Bioavailability enhancement is forecast to represent 42% of performance-claim demand in 2026, making it the leading claim category in the Fact.MR assessment.

This positioning gives premium supplement brands a measurable product story. However, the scientific basis for a bioavailability claim must be connected to the specific active, formulation, dose, and delivery system rather than assumed from the presence of a liposome.

Recent industry activity illustrates this distinction. Sibelius Natural Products and LipoActive partnered in January 2026 around the EncapSure liposomal technology platform, emphasizing heat-free production and reduced excipient use for nutraceutical applications.

Natural Field also introduced its NF Co-Loading co-encapsulated liposome technology at Vitafoods Europe 2026, positioning the system for multiple active ingredients and specialized nutritional formulations.

These developments point toward a more technical market. Delivery-system suppliers are competing through formulation architecture, processing conditions, active compatibility, and application support.

Liquid Concentrates Lead Delivery Formats

Liquid concentrates are expected to capture 32% of the delivery-format segment in 2026.

The format fits drops, liquid shots, sachets, and beverage premixes, giving manufacturers flexibility in developing products outside conventional tablets and capsules. Dry powders remain important where manufacturers need easier shipping, improved handling, or integration into solid-dose formulations.

Capsule and softgel fills also remain relevant, particularly for products where consumers prefer familiar dosage formats.

The formulation challenge is stability. Liposomes can be sensitive to oxidation, temperature, pH, ionic strength, processing conditions, and storage time. As a result, suppliers increasingly need to provide technical data alongside ingredient samples.

United States Leads Market Growth

The United States is projected to grow at 15.7% CAGR through 2036, the fastest rate among the major countries covered by Fact.MR. Strong supplement consumption and premium vitamin formats are expected to support demand.

Germany follows at 14.9% CAGR, supported by online supplement purchasing and scrutiny across pharmacy and health-retail channels. Switzerland is forecast to advance at 13.2% CAGR, while Japan is expected to grow at 12.5% CAGR, reflecting demand for evidence-backed functional nutrition formats.

The United Kingdom is projected to record a 10.3% CAGR through 2036, with dose-form clarity and retail oversight shaping product development.

The regional pattern suggests that premium delivery technologies will gain traction fastest where consumers already pay for differentiated supplement formats and where manufacturers can substantiate product-performance claims.

Competitive Landscape

The competitive landscape includes Lipoid GmbH, PlantaCorp GmbH, Botanic Healthcare, Natural Field Co., Ltd., and Eskag Pharma. Competition centers on phospholipid sourcing, carrier architecture, particle-size control, payload compatibility, stability, encapsulation performance, and formulation support.

Recent market activity indicates a broader competitive field. Wooree Green Science entered the U.S. market with LipoPrime, while Natural Field demonstrated co-encapsulation technology at Vitafoods Europe 2026. Samarth Biorigins is expanding customized delivery-system manufacturing in India.

For supplement companies, supplier selection is likely to increasingly depend on technical documentation and scale-up capability rather than ingredient availability alone.

Liposomal Nutrient Carriers Market Snapshot

2025 market value: USD 1.1 billion
2026 market value: USD 1.2 billion
2036 projected value: USD 4.4 billion
CAGR, 2026–2036: 13.9%
Absolute opportunity: USD 3.2 billion
Leading carrier architecture: Phosphatidylcholine liposomes, 43%
Leading payload: Vitamins, 34%
Leading delivery format: Liquid concentrate, 32%
Leading performance claim: Bioavailability enhancement, 42%
Fastest-growing country: United States, 15.7% CAGR
Unlock 360° insights for strategic decision making and investment planning:https://www.factmr.com/report/liposomal-nutrient-carriers-market

Report Scope and Methodology

The Fact.MR study covers lipid vesicle and phospholipid carrier systems used to deliver vitamins, botanicals, minerals, omega actives, and selected specialty payloads in supplement and functional-nutrition formats.

The market is segmented by carrier architecture, payload, delivery format, performance claim, and region. Carrier architectures include phosphatidylcholine liposomes, multilamellar liposomes, nano-liposomes, dry liposomal powders, and hybrid lipid vesicles. Delivery formats include liquid concentrates, dry powders, capsule and softgel fills, functional beverage premixes, and topical or other formats.

Fact.MR applies a hybrid top-down and bottom-up approach, incorporating supplement-format demand, lipid-carrier adoption, payload mapping, country-level evidence, and supplier portfolio analysis. The assessment distinguishes liposomal nutrient carriers from broader drug-delivery systems by focusing on nutritional and functional-food applications.

Explore More Related Studies Published by Fact.MR Research

Health Economics and Outcomes Research Services Market- https://www.factmr.com/report/health-economics-and-outcomes-research-services-market

Healthcare Agentic Artificial Intelligence Market- https://www.factmr.com/report/healthcare-agentic-artificial-intelligence-market

Healthcare AI Consulting Services Market- https://www.factmr.com/report/healthcare-ai-consulting-services-market

Healthcare and Medical Devices Testing Inspection and Certification Market= https://www.factmr.com/report/healthcare-and-medical-devices-testing-inspection-and-certification-market

Healthcare Computerized Maintenance Management System Market- https://www.factmr.com/report/healthcare-computerized-maintenance-management-system-market

About Fact.MR

Fact.MR is an initiative of Eminent Research and Advisory Services, providing market intelligence and syndicated research across food and beverage, healthcare, consumer goods, technology, industrial goods, and other sectors. The company operates from offices in Rockville, Maryland, United States, and Dublin, Ireland.

Media Contact

Fact.MR
11140 Rockville Pike, Suite 400
Rockville, MD 20852, United States
Tel: +1 (628) 251-1583
Email: [email protected]

Suite 9884, 27 Upper Pembroke Street
Dublin 2, Ireland
Tel: +353-1-4434-232

Disclosure

This release is based on Fact.MR syndicated research. Market figures represent estimates and forecasts available as of the publication date and may be revised as additional information becomes available.